RKDA · Arcadia Biosciences Inc. Common Stock
View on chartInsiders & Stakes
| Pamela Haley Chief Financial Officer | ▲ Buy | Open Market | 5,088 Shares held | 8/1/2022 | View profile |
| Stanley Jacot Jr. Chief Executive Officer | ▲ Buy | Open Market | 5,000 Shares held | 5/30/2023 | View profile |
| Thomas J. Schaefer Chief Financial Officer | ▲ Buy | Open Market | 2,819 Shares held | 2/3/2025 | View profile |
| Mark Kawakami Chief Financial Officer | ▲ Buy | Open Market | 2,681 Shares held | 2/3/2025 | View profile |
Transaction History
| Mark Kawakami | ▲ Buy | Open Market | 700 | $2K | 2/3/2025 |
| Thomas J. Schaefer | ▲ Buy | Open Market | 700 | $2K | 2/3/2025 |
| Thomas J. Schaefer | ▲ Buy | Open Market | 700 | $1K | 8/1/2024 |
| Mark Kawakami | ▲ Buy | Open Market | 700 | $1K | 8/1/2024 |
| Thomas J. Schaefer | ▲ Buy | Open Market | 700 | $1K | 2/1/2024 |
| Thomas J. Schaefer | ▲ Buy | Open Market | 649 | $2K | 8/4/2023 |
| Stanley Jacot Jr. | ▲ Buy | Open Market | 5,000 | $22K | 5/30/2023 |
| Thomas J. Schaefer | ▲ Buy | Open Market | 700 | $161 | 2/1/2023 |
| Pamela Haley | ▲ Buy | Open Market | 700 | $490 | 8/1/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
Arcadia Biosciences sees unusual volume and new 15.7% stake by MJL Manager
Arcadia Biosciences traded with higher than normal volume during Wednesday’s session, drawing attention from market watchers. A Form 13G filing revealed that MJL Manager now owns 15.7% of the company as of August 13, adding a new significant shareholder. The move could influence investor perception and liquidity. The stock remains below its 52‑week low, with an RSI of 26.0.
Arcadia Biosciences sees unusual volume and new 15.7% stake by MJL Manager. Arcadia Biosciences traded with higher than normal volume during Wednesday’s session, drawing attention from market watchers. A Form 13G filing revealed that MJL Manager now owns 15.7% of the company as of August 13, adding a new significant shareholder. The move could influence investor perception and liquidity. The stock remains below its 52‑week low, with an RSI of 26.0.